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Advanced glycation end products (AGEs) that arise from the reaction of sugars with protein side chains are supposed to be involved in the
pathogenesis of several diseases and therefore the effects of AGEs on cells are the objective of numerous investigations. Although different
cellular responses to AGEs can be measured in cell culture studies, knowledge about the nature of AGE-binding and the involved cell surface
receptors is poor. The measurement of AGE-binding to cell surfaces bears the potential to gain a deeper understanding about the nature of AGE-
binding to cell surface proteins and could be applied as a preliminary test before performing cell culture studies on AGE effects. Herein, a new
material and method for the detection of AGE-binding to cell surfaces is introduced, which has the potential to facilitate the detection of binding.
In the present paper, the detection of AGE-binding to cell surface proteins using an artificial system of cellular membrane proteins reconstituted on
beads (TRANSIL CaCo-2) is described. The binding of a BSA-AGE derived from a 37 °C incubation with 500 mM Glc (BSA-Glc 500) and the
corresponding control to this artificial system was compared with the binding to intact cells and was found to be in good agreement. Additionally,
the Kd for the binding of the BSA-Glc 500 used in the study to CaCo-2 surfaces was determined using FITC-labelled samples in a flow cytometric
approach. Competitive binding studies were performed using a set of non-labelled BSA-AGEs to compete with FITC-labelled BSA-Glc 500 for
the cell surface binding sites. The binding was found to be inhibited to different extends, virtually depending on the degree of arginine
modifications within the modified protein used for competition. Additionally, the effects of all AGEs used in the study on CaCo-2 cells was
measured using the detection of reactive oxygen species (ROS), which are known to be induced as a primary result of AGE-receptor binding. The
induction of ROS was found to linearly correlate to the capacity of the individual AGE to displace FITC-labelled BSA-Glc 500 in competitive
binding studies. Therefore, the data indicate, that at least in case of CaCo-2 cells the detection of cell surface binding can serve as a reliable
preliminary test for a potential cell-damaging effect of AGEs.
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Advanced glycation end products (AGEs) arise from a
complex nonenzymatic multi-step reaction of reducing sugars
with proteins, namely their amino acid side chains. In vivo,Abbreviations: AGEs, advanced glycation end products; DMEM, Dubelco's
modified Eagle's medium; Egg PC, egg yolk phosphatidylcholine; FCS, foetal
calf serum; FITC, fluorescein isothiocyanate; Glc, glucose; H2DCFDA,
dichlorodihydrofluorescein diacetate; MALDI-TOF MS, matrix-assisted laser
desorption ionization time-of-flight mass spectrometry; MG, methyl glyoxal;
RAGE, receptor for AGEs; RFU, relative fluorescence units; ROS, reactive
oxygen species
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doi:10.1016/j.bbamem.2007.03.021numerous proteins, particularly long-lived proteins, are found to
be AGE-modified. In cell culture studies AGEs were found to
induce cellular activation associated with chemotaxis, oxidative
stress, and cell proliferation or programmed cell death [1], and
are suspected to be involved in the pathogenesis of several
diseases such as chronic clinical complications of diabetes [2],
renal failure [2], and Alzheimer's disease [3].
The best known receptor for AGEs is the multi-ligand
receptor RAGE (receptor for AGEs), which was previously
demonstrated to be present in CaCo-2 cells [4]. RAGE is a
transmembrane protein of the immunoglobuline superfamiliy
with a molecular mass of 45 kDa, that was shown to be present
in several cell types such as endothelial cells, monocytes,
microglia, and neurons [5]. The AGE binding to RAGE was
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species (ROS) and hence induces processes related to cellular
activation and inflammation [6] such as an activation of p21ras,
MAP kinases and NF-κB [5]. However, there are also several
other proteins identified, that were found to bind AGEs such as
macrophage scavenger receptors [5], oligosaccharyl transfer-
ase-48 [5,7], or FEEL-1 and FEEL-2 [8]. The function of AGE-
binding to most of these proteins is largely unknown but some
of them are likely to mediate cellular effects of AGEs [1,9].
Therefore, not only the binding to RAGE but also the binding
to other proteins is likely to be involved in transducing cellular
effects of AGEs. Hence, dealing with biochemical effects of
AGEs is a very complex subject since a large number of
different AGE structures are potential ligands for a large
number of binding proteins, of which probably only a small
number is identified. Proper cause–effect relations are almost
impossible to follow when investigating biochemical effects of
AGEs on cells. Due to the fact that the function of many of the
AGE-binding proteins is largely unknown and that there are
probably other proteins yet to be identified, researchers are
additionally faced with the problem to find appropriate cellular
parameters, which are activated in the presence of AGEs.
Hence, when dealing with effects of AGEs on cells, it might be
advantageous to measure AGE-binding to cell surface proteins
before starting to search for their biochemical effects, since cell
binding can be assumed to be a precondition for mediating
cellular effects.
The binding of differently prepared AGEs to intact cells or
purified and isolated RAGE has been measured by different
groups [e.g. 10–12]. However, due to the existence of other
receptors the binding to RAGE might not be sufficient for the
estimation of possible cellular effects. Therefore, it seems to be
a better approach to assess the binding to an intact cell surface.
On the other hand, measuring the binding of AGEs to intact
cells is relatively time consuming, dependent on the stability of
the cells during the assay, and bears the risk of AGE-
internalisation. To overcome the problems, which result from
the use of intact cells, we designed an artificial system in which
the membrane proteins of the target cell line are embedded in a
lipid bilayer and reconstituted on a bead surface. These beads
can be produced in stable, homogenous batches and therefore,
the system provides optimised conditions for performing
extensive test series with a high number of data points. Another
important advantage is the strongly increased sensitivity of this
artificial system as compared with intact cells, that allows the
use of nanomolar sample concentrations. Additionally, the
rigidity of the bead-based system allows the use of harsher
conditions for sample preparations. Therefore, the assay can
easily be performed on a high throughput scale. For the present
study the binding of a glucose derived BSA-AGE (BSA-Glc
500, AGE formation at 37 °C) to CaCo-2 cells and to the
artificial membrane–protein system was compared and the
binding constant (Kd) for the binding of BSA-Glc 500 to CaCo-
2 surfaces was determined. To exclude the possibility that the
detected binding is due to a binding to the lipid moiety of the
cell surface, the binding to an artificial lipid surface was
compared with the binding to the membrane–protein containingsurface. Additionally, competitive binding studies using BSA-
Glc 500 versus other AGEs were performed. The binding of
BSA-Glc 500 to intact cells was found to be in agreement with
the binding to the bead-based membrane system, whereas the
non-specific binding to pure lipid surfaces is negligible. The
binding constant of BSA-Glc 500 to CaCo-2 surfaces could be
determined using a fluoresceine-based flow cytometric assay
and was comparable with the results from other AGE-receptor
binding studies. Methyl glyoxal (MG) derived BSA-AGEs and
more highly modified glucose derived BSA-AGEs were found
to compete with BSA-Glc 500 for the same binding sites.
Additionally, all AGEs used for competitive binding studies
were tested for their ability to induce the formation of
intracellular ROS in CaCo-2 cells. The ROS formation in
cultured CaCo-2 cells was found to linearly correlate with the
capacity to inhibit the binding of FITC-labelled BSA-Glc 500 in
competitive binding tests. Therefore, the obtained data provide
evidence, that surface binding is directly correlated to the ability
of an AGE to induce ROS. Hence, AGE-binding to the
described bead-based membrane system seems to be a good
indicator for the ability of an AGE to induce intracellular ROS
in CaCo-2 cell culture experiments.
2. Materials and methods
2.1. Materials
Chemicals were purchased from the following suppliers: Sigma/Aldrich
(Germany): BSA (99%, gamma globulin free, Cat. no.: A 3059), FITC, EDTA,
fluorescamine, and methyl glyoxal (MG); Roth (Germany): components for
PBS and carbonate buffer; Pierce (Germany): BCA reagent 1 and 2; Fluka
(Germany): 2,4-dinitrophenyl hydrazine (2,4-DNPH), and 9,10-phenanthrene-
quinone; and Merck (Germany): glucose monohydrate (Glc).
CaCo-2 cells were obtained from DSMZ (Germany). Dulbecco's modified
Eagle's medium (DMEM) and all other components for the cell culture media
were purchased from GibcoBRL, Germany. Accutase was purchased from PAA
Laboratories (Austria).
2.2. Preparation of AGE modified BSA
AGE modified BSA for binding tests (BSA-Glc 500, BSA-AGE) was
prepared by incubating 4 mg/ml BSA in 0.5 M phosphate buffer, pH 8.0,
containing 1 mM NaN3 and 1 mM EDTAwith 0.5 M glucose (Glc) for 6 weeks
at 37 °C under sterile conditions. All glassware and the buffer were autoclaved
prior to use to inactivate proteases. BSA incubated under the same conditions
but without added modifier was used as control. After the incubation, protein
solutions were extensively dialysed against 10 mM phosphate buffer, pH 7.4 and
stored at −20 °C. Protein concentrations were determined using the BCA assay
according to the supplier's protocol.
2.3. Characterization of the modified proteins
Characterization procedures were performed as previously described in
detail [13]. Briefly, the number of reacted lysine residues was determined using
fluorescamine. Reacted arginine was assayed using 9,10-phenanthrenequinone
as described previously [13,14]. The CML content was determined by CML-
ELISA kit (kindly provided by Roche Diagnostics, Penzberg, Germany)
according to the supplier's protocol and the carbonyl content was assayed using
2,4-DNPH as previously described [13,15]. AGE-specific absorbance was read
at 360 nm and AGE-specific fluorescence was detected at excitation/emission
wavelengths of 330/395 nm, 365/440 nm, and 485/530 nm [13]. Additionally,
changes in intrinsic protein fluorescence were detected at excitation/emission
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corresponding control. Freshly prepared BSA solution was used as an additional
control in all cases.
The masses of the non-modified and modified proteins were detected by
MALDI-TOF MS as described previously [16].
2.4. FITC labelling of samples and determination of the labelling rate
FITC-labelling was performed in 100mM carbonate buffer, pH 9.5 with a final
protein concentration of 1 mg/ml and a final FITC concentration of 0.1 mg/ml.
After 1 h incubation at room temperature sampleswere extensively dialysed against
PBS, aliquoted and stored frozen at −70 °C.
The FITC labelling rates were determined by detecting the mass difference
of FITC labelled proteins and non-labelled proteins using a BRUKER
DALTONICS autoflex MALDI-TOF mass spectrometer.
2.5. Cell culture
CaCo-2 cells were grown in cell culture flasks (75 cm2, Greiner) in DMEM
supplemented with 20% FCS, glutamine, non-essential amino acids and
penicillin/streptomycin at 37 °C, 5% CO2 and 95% humidity until confluence
and harvested with Accutase. Cells for binding tests were counted in a CASY 1
cell counter (Schärfe, Germany).
Cells for the preparation of membrane proteins were grown until confluence
and harvested with 1 mM EDTA in PBS. Cells were washed twice with PBS and
stored at −70 °C until use.
2.6. Beads
Beads containing lipid bilayers made of egg yolk phosphatidylcholine
(TRANSIL Egg-PC) and beads with reconstituted membrane proteins of
CaCo-2 embedded in a lipid bilayer (TRANSIL CaCo-2) are proprietary
products of NIMBUS Biotechnologie GmbH, Leipzig, Germany (Patent
numbers: US6868343, and WO02095406). The bead-reconstituted proteins
can freely move throughout the surface and have the same orientation as in
the cellular system as proven by the accessibility of sialidase and
acetylcholine esterase activity as described previously [17]. The protein
containing membranes are non-covalently immobilized on surface optimised
silica beads in order to retain the membrane fluidity [18] and protein function
[19].
2.7. Binding tests with intact cells
Binding tests with intact cells were performed as described previously
[20] Briefly, 2×105 cells and FITC-labelled protein-sample were mixed in a
total volume of 100 μl and incubated at room temperature in the dark.
Unlabelled BSA at a final concentration of 75 mg/ml was used to block non-
specific binding. FITC-labelled control for BSA-Glc 500 and freshly
prepared BSA were used as controls. After binding, the samples were
washed 3 times with PBS with intermediate centrifugation. The washed pellet
was resuspended in 1 ml PBS (containing 0.05% BSA), filtered through
nylon mesh strainer caps (BD Biosciences) and analysed in a FACSVantage
SE (BD Biosciences) with excitation and emission wavelengths of 488 and
530 nm.
2.8. Binding tests with bead-reconstituted membranes and artificial
membranes
Approximately 5×104 beads were mixed with FITC-labelled sample and
incubated for 15 min to 1 h in a final volume of 100 μl at room
temperature. 75 mg/ml BSA was used to block non-specific binding. After
incubation samples were transferred into Multiscreen HV filter plates
(catalogue number MAHV N45, Millipore) and the beads were washed 3
times with 250 μl PBS each. Beads were resuspended in 500 μl PBS
(containing 0.05% BSA) immediately before flow cytometric analysis in a
FACSVantage SE (BD Biosciences) with excitation and emission wave-
lengths of 488 and 530 nm.2.9. Competitive binding studies
AGEs for competitive binding tests were prepared by incubating 4 mg/ml
BSAwith 10, 20 and 50 mM methyl glyoxal at 37 °C (BSA-MG 10, 20 and 50)
and with 100, 200 and 500 mM Glc at 50 °C (BSA-Glc 100, 200, and 500,
50 °C). Incubation was performed using the same buffers and additives as
described above for 4 weeks. All samples were dialysed and stored as described
above.
Competitive binding tests were performed using 0.22 μM FITC labelled
BSA-Glc 500 with a 10fold excess of non-labelled samples as described above
with a 1-h incubation.
2.10. Reactive oxygen species assay
The AGE-induced formation of reactive oxygen species was measured using
dichlorodihydrofluorescein diacetate (H2DCFDA) as described previously
[21,22] with some modifications. 10,000 cells per well were seeded in a total
volume of 100 μl medium (as described in the cell culture paragraph) in 96-well
cell culture plates (TPP, Switzerland) and grown for 48 h. The medium was
removed and each well was washed with 150 μl Hank's balanced salt solution
(HBSS) before loading the cells with H2DCFDA (100 μl, 0.1 mM in HBSS) for
1 h. The dye reagent was removed and the wells were washed with 150 μl
HBSS. Samples were added in a total volume of 100 μl with a protein
concentration of 10 μM in HBSS. Freshly prepared BSA-solution was used as
control. After a 20-h incubation the fluorescence was read at excitation/emission
wavelengths of 485/520 nm in a FLUO-Star reader (BMG, Germany). Wells
containing cells and protein but no dye were used to correct the detected signals
for the AGE fluorescence.
3. Results and discussion
3.1. Characterization of the modified proteins used in the study
The characterization data of all modified proteins used in the
study are given in Table 1 (molecular masses and side chain
modifications) and Table 2 (spectroscopic data). The AGEs
were prepared at 37 °C unless otherwise stated. The BSA-AGEs
derived from the incubation with Glc at 50 °C and with MG
show the highest degrees of modification, although the degree
of arginine modification is higher for MG derived than for Glc
derived modified BSA. Accessible CML groups were found in
all modified proteins. The highest numbers of CML-modifica-
tions were detected in the Glc derived BSA-AGEs produced at
50 °C, while the CML-content of the proteins modified with
MG is relatively low. The carbonyl content, which is a good
indicator for the formation of stable AGE-structures [23] is
highest in 50 mM MG derived BSA-AGEs followed by the
AGE from in the incubation with 500 mM Glc at 50 °C.
AGE-specific absorbance was detected at 360 nm. The given
data are normalized to the absorbance at 280 nm of the
corresponding control since non-modified BSA shows no
absorbance at 360 nm [13]. The highest AGE-specific
absorbance was detected for BSA-MG 50 followed by BSA-
MG 20. Changes in the protein structure were detected using the
intrinsic protein fluorescence of tryptophan. The native structure
was found to be significantly affected in all modified proteins.
This effect was most pronounced for BSA-MG 50, where the
intrinsic protein fluorescence was completely vanished. AGE-
specific fluorescences were detected at the wavelengths
indicated and were found to be very high for all modified
proteins. The decrease in the AGE-specific fluorescences with
Table 1
Data for AGE-characterization for the AGEs used in the study
MW [Da] Lysine % modified Arginine % modified mol CML/mol BSA mol carbonyl/mol BSA
BSA 66553 0 0
BSA-Glc 500 71582 69 30 1.14 3.3
Control BSA-Glc 500 66475 0 0 0 0
BSA-MG 10 71808 59 67 0.09 4.4
BSA-MG 20 72177 82 78 0.41 7.1
BSA-MG 50 76484 96 88 0.95 12.0
Control BSA-MG 10–50 66562 0 0 0 0
BSA-Glc 100, 50 °C 70673 67 53 4.90 3.8
BSA-Glc 200, 50 °C 72896 86 62 5.13 5.0
BSA-Glc 500, 50 °C 75774 95 73 5.34 7.2
Control BSA-Glc 100–500, 50 °C 66478 0 0 0 0
The data from absorbance or fluorescence based measurements are given either in % modified compared to the corresponding control (degree of reacted arginine and
lysine side chains) or in mol modifications per mol BSA (CML and carbonyl groups).
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previously published data [13]. Compared with fresh BSA, the
BSA control incubated at 50 °C without modifier shows
significantly affected spectroscopic data (data not shown in
Table 2). The intrinsic protein fluorescence was found to be
reduced to 70% of the value obtained with fresh BSA and the
AGE-specific fluorescences were enhanced by a factor of 6, 12,
and 4 at excitation/emission wavelengths of 330/395 nm, 365/
440 nm, and 485/530 nm, respectively, when compared with
fresh BSA. This is probably a result from the relatively drastic
incubation conditions, which are likely to affect the native
protein structure, and from ongoing AGE-formation processes
of already existing glycation-structures within the virtually non-
modified protein. All other controls showed only slightly
enhanced AGE-fluorescences when compared with fresh BSA.
3.2. Comparison of results from intact cells and from
membranes reconstituted on beads
The binding of BSA-AGE (BSA-Glc 500) to intact CaCo-2
cells and the optimisation of the assay conditions has been
previously published [20]. For the recent study, membrane
proteins from CaCo-2 cells were reconstituted on beads and
used for binding tests. The binding of BSA-Glc 500 to the bead-
based membranes was compared with the binding to intact cells.Table 2
Spectroscopic data for the AGEs used in the study
A [360]
AU
Fluo [280/350]
% of control
BSA-Glc 500 0.36 10
Control BSA-Glc 500 0 100
BSA-MG 10 1.10 1.7
BSA-MG 20 2.10 0.5
BSA-MG 50 3.61 0.0
Control BSA-MG 10–50 0 100
BSA-Glc 100, 50 °C 0.91 4.0
BSA-Glc 200, 50 °C 1.50 1.5
BSA-Glc 500, 50 °C 1.55 0.7
Control BSA-Glc 100–500, 50 °C 0 100
The data are given normalized to the corresponding control. For the AGE-specific
normalize the data.To enable a comparison of fluorescence data from different
experiments the relative fluorescence units obtained from the
FACS machine were corrected for the individual labelling rates
and normalized to the binding of non-incubated FITC-labelled
BSA. As shown in Fig. 1, the binding of BSA-Glc 500 to intact
cells corresponds well to the binding observed with bead
reconstituted membrane proteins. The binding to the bead
system was found to be slightly enhanced as compared with the
binding to intact cells, which might be a result of an enhanced
protein number on the surface of the beads as compared with
cells. Another possible explanation might be the use of different
harvesting procedures. While cells for measurements with intact
cells were harvested with the proteases containing Accutase,
EDTA was used to detach cells for the preparation of
immobilized membranes. Although it is a mild reagent for
cell harvest, Accutase treatment can possibly damage cell
surface proteins, what is excluded when treating cells with
EDTA. However, the data clearly show, that the used bead based
system can be applied to mimic the AGE-binding to a cell
surface. Therefore, it is well suited for the detection of protein–
protein interactions. This is additionally supported by the data
given in Fig. 2, were the concentration dependence of binding
was shown. As already shown in Fig. 1, the binding to beads is
slightly stronger than to intact cells, but as described above this
is likely to be a result of an enhanced receptor number on theFluo [330/395]
normalized control
Fluo [365/440]
normalized control
Fluo [485/530]
normalized control
32 32 34
1 1 1
47 40 95
24 39 122
11 15 123
1 1 1
19 12 65
18 11 85
14 8 79
1 1 1
absorbance at 360 nm the absorbance of BSA control at 280 nm was used to
Fig. 1. Binding of FITC-labelled AGE (BSA-Glc 500), the corresponding
control, and fresh BSA to intact cells (light grey) and to bead reconstituted
membrane proteins (dark grey); sample concentration of 3.6 μM and 75 mg/ml
BSA for blocking. The data represent averages from 5 individual experiments
with two data points, incubation time 15 min. The fluorescence intensities have
been corrected for the individual labelling rates and normalized to the BSA-
binding to allow comparison of the data from different experiments.
Fig. 3. FACS data from a typical binding experiment using cells (circles) or
beads (squares). The concentration of FITC labelled BSA-Glc 500 was varied in
the range of 0–3.6 μM. Data are given as absolute values without further
correction.
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Additionally, when using intact cells with ligand protein
concentrations below 2 μM the FACS fluorescence signal is
very low [20] which complicates the exact detection of binding
data for low sample concentrations. As shown in Fig. 3, the
fluorescence detected in FACS experiments is much stronger
when using beads instead of cells. The figure displays data from
two typical experiments. However, a comparison of absolute
fluorescences from FACS experiments is critical, as the detected
values are dependent on the instrument settings. Therefore,
normalized data should be used for a quantitative comparison ofFig. 2. Comparison of the concentration dependence of the binding to beads (grey) a
15 min in the presence of 75 mg/ml BSA for blocking the non-specific binding. The
labelling rates and normalized to the binding obtained with the highest concentratiodata from experiments with cells and beads as shown in Figs. 1
and 2. When comparing absolute data from two typical
experiments with cells and beads as shown in Fig. 3, an
enhancement of the detected background signal (cells or beads
without FITC labelled sample) by a factor of 3 is obtained when
using a sample concentration of approximately 0.2 μM BSA-
Glc 500 when using cells compared with a concentration of
7 nM when using beads. Hence, the bead system can be
assumed to provide a much higher sensitivity than intact cells,
while both systems yield comparable data when the detected
fluorescences are normalized to the binding of non-AGE-
modified BSA (Figs. 1 and 2), given that the sample
concentration is sufficiently high (≥0.2 μM) to yield detectable
signals when using cells.
Summarizing, it can be stated that the use of bead-
reconstituted cell surface proteins is well suited to mimic the
binding of AGEs to the surface of intact cells and to overcome
the problems resulting from the use of intact cells. The use of
the described artificial bead-based system provides numerousnd intact cells (black) for AGE (A), control (B), and BSA (C), incubation time
bindings were determined in duplicate and are given corrected for the individual
n of BSA used in the individual experiment.
Fig. 5. Binding curve of BSA-Glc 500 (black) and fresh BSA (grey) for the
binding to TRANSIL CaCo-2 surfaces. Data were obtained in duplicate for
concentrations 0–3.6 μM for AGE and 0–6.6 μM for BSA after incubation for
1 h in the presence of 75 mg/ml BSA for blocking the non-specific binding.
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preparation are simplified when using beads and the possibility
of long-term bead-storage makes the experiments flexible and
almost independent from cell culture. Among the most
important advantages is the strongly increased sensitivity of
the bead-based system over intact cells. As previously
published the sensitivity in the cell-based assay was rather
poor and sample concentrations below 0.4 μM should not be
used due to the low fluorescence detected in the flow cytometer
[20]. The application of beads with reconstituted membrane
proteins allows the use of sample concentrations of as low as
7 nM in the binding assay and hence enables the determination
of the binding constant Kd for the binding of an AGE to a cell
surface. An additional advantage of the bead-based system is
the possibility to use filter plates in the sample preparation
procedure (wash of unbound sample). The application of 96-
well filter plates allows the processing of a much higher sample
number per experiment than would be possible with intact cells,
where each individual sample has to be washed in a separate
tube. When using filter plates for the washing procedure the loss
of beads is reduced to a minimum and the sample preparation is
less time consuming as compared with the use of cells.
Therefore, more extensive test series with a higher number of
data points can be performed when using the bead system.
3.3. Stability of the membrane coated beads
The stability of the used material upon storage at −75 °C in
PBS was proven for a period of 85 days. As shown in Fig. 4 the
detected binding is not significantly affected by long term
storage of the material. The slight differences between the
different experimental data are in the range of deviation of the
results obtained with intact cells in independent experiments
(data not shown). Therefore, the artificial membrane system is
stable upon storage in PBS at −75 °C without significant effects
on the detected binding. Additionally, the data prove that
individual experiments performed with beads from the same
preparation lot yield comparable results.Fig. 4. The storage stability (−75 °C, in PBS) of the membrane coated beads was
tested by measuring the binding of AGE and the corresponding control (in
duplicate) over a period of 85 days with standard assay conditions (sample
concentration 3.6 μM, 15 min incubation, 75 mg/ml BSA). The fluorescence
intensities have been corrected for the individual labelling rates and were
normalized to the binding of BSA.3.4. Determination of the Kd
Binding constants (Kd) for AGE-binding either to intact cells
or isolated RAGE have been previously determined using
different methods [e.g. 24,25]. However, when discussing
binding constants for AGEs one has to consider, that the indi-
vidual Kd is only valid for the specific AGE used in the
according study, because the Kd will be dependent on the
number and kind of modifications within the protein. Therefore,
utmost care is required when discussing and comparing binding
data from different studies.
The total recorded binding curve for BSA-Glc 500 is shown
in Fig. 5. The binding of fresh BSA, that is assumed to be non-
specific, is given in the same figure to allow a comparison of the
binding data. The binding curve of the individual BSA-Glc 500
used in this study was determined using a fixed number of beads
with an AGE concentration range of 0.007–3.6 μM. The Kd
was obtained using a Hanes–Woolf plot. The resulting binding
constant was found to be 0.36 μM±0.07 μM (average from two
individual experiments with two repeats for each data point).
This value is in the same order of magnitude as values formerly
published by other groups: Kd≈0.5 μM, human and rat
mesangial cells, AGE derived from the incubation of BSA
with glucose-6-phosphate [24]; Kd≈0.1 μM, RAGE-trans-
fected 293 cells, AGE derived from the incubation of BSAwith
glucose-6-phosphate [26]; or Kd≈0.7 μM, human monocytes,
AGE derived from the incubation of BSA with glucose-6-
phosphate [27]. However, also higher affinities of AGEs were
reported, e.g. a Kd of 43 nM for the binding of an AGE derived
from the incubation of BSAwith glucose-6-phosphate to cells of
bovine aortic endothelium [28]. As mentioned above the Kd is
dependent on the degree of modification within the protein and
the chemical nature of the modifications formed. Additionally,
the cell type and the composition of cell surface proteins is
important for the detected binding constant. Therefore, a Kd is
only valid for one individual AGE-modified protein and the
cells used for the study. Hence, a comparison of binding data
from different studies without exact knowledge about all
experimental parameters and the AGE used is difficult, if not
Fig. 7. Binding of 0.22 μM FITC-labelled BSA-Glc 500 was blocked using a
10fold excess of non-labelled BSA-Glc 500 and modified BSA derived from
incubation with 10, 20 and 50 mMMG at 37 °C and 100, 200 and 500 mM Glc
at 50 °C. BSA incubated at 50 °C was used as a control for the AGEs that were
prepared at 50 °C. Binding was performed for 1 h. All data represent averages
from 3 individual experiments and are given normalized to the binding of FITC
labelled BSA-Glc 500, 37 °C without added competitor.
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characterization data of the AGE used in a study, such as the
degree of modification and the spectroscopic parameters is
required.
3.5. Detection of non-specific binding to artificial Egg-PC
membranes
As the membrane proteins on the beads surface are
embedded in a lipid bilayer (as they are also in intact cells), it
should be excluded that the detected AGE-binding is due to
interactions of the protein with the lipid moiety of the surface.
The non-specific binding to the lipid moiety of the membrane
was measured using beads coated with an artificial membrane
made of egg yolk phosphatidylcholine (Egg-PC) [19], in order
to evaluate the contribution of the lipid membrane to the
detected binding.
As shown in Fig. 6 the lipid–membrane binding of BSA-Glc
500 as well as the controls is negligible. The lowest lipid
binding was observed for the AGE-modified BSA and is found
to be only 3% of the binding to reconstituted CaCo-2-membrane
surfaces. This low binding might be due to the polar and
hydrophilic nature of the AGE-modifications, that are often
charged groups. The binding of fresh BSA (15% of CaCo-2
binding) and the incubated control (10% of CaCo-2 binding) to
Egg-PC surfaces was found to be quite similar even though the
binding of the incubated control is slightly enhanced over the
binding of fresh BSA. The percentage of non-specific lipid
binding compared with CaCo-2 binding is found to be similar in
the concentration range from 0.007 to 3.6 μM (data not shown).
As proven in this experiment, none of the proteins used in the
present study have a noteworthy affinity to the lipid moiety of a
membrane surface. Therefore, it can be concluded that theFig. 6. Binding of FITC-labelled samples to bead-reconstituted CaCo-2 and to
Egg-PC surfaces; sample concentration: 0.3 μM, incubation for 1 h in the
presence of 75 mg/ml BSA. All data were corrected for the individual labelling
rates.detected binding to the reconstituted membranes is due to
protein–protein-interactions with a negligible contribution of
lipid membrane affinity.
3.6. Competitive binding studies
The binding of FITC-labelled BSA-Glc 500 was tested in
competition with a 10fold excess of other modified proteins. All
modified proteins used were characterized with respect to the
most important AGE-specific parameters (see Tables 1 and 2).
As shown in Fig. 7 all tested AGEs are able to compete with
FITC-labelled BSA-Glc 500 and thus the binding can be
considered as specific. Interestingly, the strongest inhibition of
the binding of FITC-labelled BSA-Glc 500 was observed in the
presence of BSA modified with 50 mM MG. Therefore, it can
be concluded, that the binding motif formed by incubation of
BSA with glucose is equal or at least similar to structures
derived from the incubation with MG. This thesis is also
supported by findings by Shamsi et al., who found, that
antibodies against MG-derived AGEs cross-react with proteins
modified with glucose, fructose, ribose and some intermediates
of the AGE-formation process [29]. A strong inhibition of the
binding of FITC-labelled BSA-Glc 500 was also achieved with
AGE-proteins derived from the incubation with Glc at 50 °C,
whereas the non-labelled BSA-Glc 500, 37 °C caused a
decrease in the detected binding of only 11%. The reason for
this weak displacement capacity of unlabelled BSA-Glc 500,
37 °C might be the incomplete occupancy of available receptors
by the labelled sample. The sample concentration used for the
experiment is quite low (below the detected Kd) and the degree
of modification of this protein is significantly lower than in
Fig. 9. Data obtained for the stimulation of CaCo-2 cells with differently
modified BSA. The stimulation was performed for 20 h with a sample
concentration of 10 μM in HBSS. The data are given normalized to the signal
obtained with fresh BSA.
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degree of binding inhibition seems to correlate to the degree of
arginine modifications within the modified protein (Fig. 8A,
coefficient of determination, R2 =0.91) and not with the degree
of lysine modifications (Fig. 8B, R2 =0.51). When correlating
the data it should be considered that for the AGEs used in the
present study the range of arginine modifications (30–88%) is
larger than the range of lysine modifications (59–95%). Hence,
the different ranges might influence the results of the data
correlations. To exclude this possibility, the correlation was
tested when excluding the arginine modification of BSA-Glc
500, 37 °C (30% of arginine residues modified) from the data.
Even in this case there is a stronger correlation of the
displacement data with the degree of arginine modifications
(R2 =0.74, data not shown) than with the degree of lysine
modifications.
Even though the modification of arginine and lysine is
related to each other, the relative degree of modification
depends on the nature of the modifier. It is known, that during
long term incubation with Glc or MG both amino acids are
modified to a different extend [13]. With Glc lysine is modified
to higher degree than arginine while with MG it is vice versa.
The data obtained in the present study provide evidence, that
mainly modifications derived from arginine are responsible for
the cell surface binding of AGE modified proteins. On the other
hand CML-modifications, that have been reported to be the
main binding motif mediating AGE-receptor-binding [25], does
not seem to be responsible for the detected binding of the BSA-
Glc 500 used in this study, as the binding of FITC-labelled
BSA-Glc 500 was inhibited in the same order of magnitude by
MG derived AGEs having a very low CML content and by Glc
derived AGEs with a very high number of CML modifications
(see Table 1).
3.7. The induction of reactive oxygen species correlates to
AGE-binding
The above described capacity to inhibit the binding of FITC-
labelled BSA-Glc 500 can be assumed to be an indirect access toFig. 8. Correlation of the degree of displacement of FITC-labelled BSA-Glc 500 vers
displacing BSA-AGE. The solid line represents a linear fit to the data.the ability of the displacing AGE to bind to the cell surface. To
prove the assumption, that the binding to the cellular surface can
be used as a preliminary test before performing cell culture
studies with AGEs, the AGE-induced formation of ROS in
CaCo-2 cells was studied. As shown in Fig. 9 the AGEs used for
displacement studies were all able to induce the formation of
intracellular ROS, as described previously [22]. Interestingly,
the induction of ROS is strongest for MG-derived AGEs
followed by Glc-derived AGEs from the incubation at 50 °C.
Therefore, these data correspond very well to the above
described capacity to inhibit the binding of FITC-labelled
BSA-Glc 500. As shown in Fig. 10 the ability of an AGE to
displace FITC-labelled BSA-Glc 500 in the described experi-
ments correlates with the ROS-formation induced by the same
AGE in cell culture experiments. Hence, the data obtained
indicate that the detected ability to bind to a CaCo-2 cell surface,
which can be accessed in a binding test directly by using a FITC-us the degree of arginine modifications (A) and of lysine modifications (B) in the
Fig. 10. Correlation of the ability to displace FITC-labelled BSA-Glc 500 with
the formation of ROS in CaCo-2 when treated with the individual AGE. BSA-
Glc 500 (squares); Glc derived BSA-AGEs, incubation at 50 °C and
corresponding control (triangles); MG-derived BSA-AGEs (circles). The solid
line represents a linear fit to the data.
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the binding of a specific AGE, is an indicator for the induction of
cellular effects. The obtained data prove a direct correlation of
the displacement capacity of an AGE with the strength of ROS
induction in CaCo-2 cells. Additionally, the above described
correlation between the capacity to displace FITC-labelled
BSA-Glc 500 with the number of modified arginine residues
indicates, that the ROS formation is also dependent of arginine
modifications. Indeed, there is a linear correlation between the
degree of arginine modification and the induction of ROS (Fig.
11A, R2 =0.95) and thus, the AGE-induced formation of
intracellular ROS can most likely be attributed to arginine
modifications. A similar correlation to the degree of lysine
modification (Fig. 11B, R2 =0.59) or any other parameter
described in the AGE-characterization paragraph could not be
observed. When excluding the 30% arginine modification of
BSA-Glc 500, 37 °C from the data evaluation as describedFig. 11. Correlation of the AGE-induced ROS formation versus the degree of arginin
solid line represents a linear fit to the data.above, the correlation of the intracellular ROS formation and
the degree of arginine modification is even stronger (R2 =0.99,
data not shown) than for the complete data range. Thus, the data
obtained in the present study and shown in Fig. 11 strongly
suggests, that arginine rather than lysine modifications are
responsible for the AGE-induced formation of ROS in CaCo-2
cells. The important role of arginine-modifications in receptor
mediated cell activation was previously postulated by Fan et al.,
who hypothesised that argpyrimidine or hydoimidazolone are
responsible for the release of TNF-α in RAW 264.7 cells treated
with MG-derived BSA-AGE [30]. However, the correlation of
the binding of AGE-modified BSA to a CaCo-2 surface and the
induction of ROS in cultivated CaCo-2 cells by the same AGE
as described in the present paper, are a proof for the direct and
linear link of AGE-induced cellular effects with cell surface
binding in CaCo-2. Still, the existence of different AGE-
receptors which potentially mediate different cellular effects
makes it difficult to predict similar correlations between the
surface binding and a detected cell damaging effect in other cell
lines. Nonetheless, it can be expected, that similar correlations
might also be found for other AGE induced cellular events or in
different cell lines— as long as they are induced by a binding
event.
Conclusively, the detection of AGE-binding to a CaCo-2 cell
surface as obtained using our artificial bead based membrane
system can be used as a preliminary test for the effectiveness of
an AGE in the induction of intracellular ROS in CaCo-2 and
therefore, probably also for cellular parameters induced by
enhanced intracellular ROS.
4. Conclusion
In the present paper we introduce the use of an artificial
system of membrane proteins (embedded in a lipid bilayer)
reconstituted on bead surfaces and describe the detection of
AGE-binding to these beads. The binding to this artificial
system was shown to be in agreement with data obtained with
intact cells and the non-specific binding to lipid membranese modifications (A) and of lysine modifications (B) in the BSA-AGE used. The
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protein-containing membrane system. Therefore, the detected
binding can be assumed to be due to protein–protein
interactions. Saturation binding experiments were performed
for BSA-Glc 500 and a Kd of 0.36 μM was calculated from the
obtained data. Additionally, competitive binding studies were
performed using different AGEs, that were found to inhibit
BSA-Glc 500 binding to different extends. The inhibition of
binding correlates to the degree of arginine modification within
the modified protein used for competition and hence, it can be
hypothesised, that the detected binding is mainly due to arginine
modifications. The ability to bind to the CaCo-2 surface (in the
used artificial bead-based system) was shown to linearly
correlate to the induction of ROS in cell culture studies with
CaCo-2 and thus, as postulated above, the detection of AGE-
binding seems to be a useful preliminary test before performing
cell culture experiments with AGEs.
The used artificial bead based membrane system provides a
highly sensitive method with fluorescence labelled samples,
which allows a large number of data points to be measured in
one experiment. The production of large bead-lots enables the
comparison of independent experiments and the possibility to
repeat experiments under identical conditions. Additionally, the
loss of material during sample preparation is reduced compared
to the use of intact cells and the cell harvest for bead-preparation
can be done without using any proteases and hence, without any
potential receptor-damage. In conclusion, the used artificial
bead assisted system was found to be an excellent tool to study
the binding of AGE-modified proteins to cell surface proteins
and could likely also be applied to study the protein–protein
interactions in similar systems.
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